Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-22

Clinical Trial Update: GOAL International QuERI - Protocol CHRC 2019 GOAL INTERNATIONAL

View source ↗

Summary

Clinical trial update for the GOAL International QuERI protocol CHRC 2019, with the study on dyslipidemia reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Dr. Anatoly Langer | Conditions: Dyslipidemia | Status: COMPLETED